AI brief of an SEC Form 8-K · Ryan Specialty (RYAN)

Ryan Specialty Q2 revenue rises 23% to $855.2 million; organic growth outlook cut

Mixed Impact 4 of 5 earnings Written later

Ryan Specialty reported second-quarter 2025 results for the period ended June 30, with total revenue up 23.0% and net income up 5.6%. The company cut its full-year 2025 organic revenue growth guidance to 9.0%-11.0% from 11%-13%, while narrowing its Adjusted EBITDAC margin guidance and declaring a $0.12 quarterly dividend.

Key points

  • Total revenue rose 23.0% year-over-year to $855.2 million; organic revenue growth slowed to 7.1% from 14.2%.
  • Net income rose 5.6% to $124.7 million; diluted EPS was $0.38 versus $0.37, and adjusted diluted EPS rose 13.8% to $0.66.
  • Full-year 2025 organic revenue growth guidance was lowered to 9.0%-11.0% from 11%-13.0%; Adjusted EBITDAC margin guidance is now 32.5%-33.0%, from 32.5%-33.5%.
  • Board declared a $0.12 per share regular quarterly dividend, payable August 26, 2025, to holders of record on August 12, 2025.

The filing

CompanyRyan Specialty (RYAN)
Form8-K, current report
Filed with the SECJul 31, 2025, 4:07 PM ET
Accession number0001628280-25-036997

Items reported: 2.02 Results of Operations8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:07 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 31, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.